Diabetes Treatment – Rybelsus (Oral Semaglutide)

¥5,500

Diabetes Treatment – Rybelsus (Oral Semaglutide)

Recovery & Physiotherapy

Tokyo Relife Clinic, Chuo

¥5,500

Rybelsus (oral semaglutide) is a GLP-1 receptor agonist taken orally to improve blood sugar control in type 2 diabetes by enhancing insulin secretion, reducing glucose production, and slowing gastric emptying

Package Included

Oral medication (3mg or 7mg semaglutide)
taken daily
available in 10-day and 30-day supply options

Benefits

Helps control blood sugar
supports weight management
improves insulin response
convenient oral administration

Preparation

Medical consultation required before prescription

Hospital

Tokyo Relife Clinic

Chuo, Japan

Offers Multiple Language Support

Committed to patient-centered care, Tokyo Relife Clinic ensures high-quality treatments tailored to individual needs.